Cargando…
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†)
While 25 compounds have been formally licensed for the treatment of HIV infection (AIDS), only seven licensed products are currently available for the treatment of chronic hepatitis B virus (HBV) infection: interferon-α, pegylated interferon-α, lamivudine, adefovir (dipivoxil), entecavir, telbivudin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185710/ https://www.ncbi.nlm.nih.gov/pubmed/21994680 http://dx.doi.org/10.3390/v2061279 |
_version_ | 1782213252451663872 |
---|---|
author | De Clercq, Erik Férir, Geoffrey Kaptein, Suzanne Neyts, Johan |
author_facet | De Clercq, Erik Férir, Geoffrey Kaptein, Suzanne Neyts, Johan |
author_sort | De Clercq, Erik |
collection | PubMed |
description | While 25 compounds have been formally licensed for the treatment of HIV infection (AIDS), only seven licensed products are currently available for the treatment of chronic hepatitis B virus (HBV) infection: interferon-α, pegylated interferon-α, lamivudine, adefovir (dipivoxil), entecavir, telbivudine and tenofovir (disoproxil fumarate). In contrast to the treatment of HIV infections where the individual drugs are routinely used in combination, for the treatment of chronic HBV infection the individual drugs are generally used in monotherapy. In principle, combination drug therapy should allow reducing the likelihood of drug-resistant development. |
format | Online Article Text |
id | pubmed-3185710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-31857102011-10-12 Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†) De Clercq, Erik Férir, Geoffrey Kaptein, Suzanne Neyts, Johan Viruses Review While 25 compounds have been formally licensed for the treatment of HIV infection (AIDS), only seven licensed products are currently available for the treatment of chronic hepatitis B virus (HBV) infection: interferon-α, pegylated interferon-α, lamivudine, adefovir (dipivoxil), entecavir, telbivudine and tenofovir (disoproxil fumarate). In contrast to the treatment of HIV infections where the individual drugs are routinely used in combination, for the treatment of chronic HBV infection the individual drugs are generally used in monotherapy. In principle, combination drug therapy should allow reducing the likelihood of drug-resistant development. Molecular Diversity Preservation International (MDPI) 2010-05-31 /pmc/articles/PMC3185710/ /pubmed/21994680 http://dx.doi.org/10.3390/v2061279 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review De Clercq, Erik Férir, Geoffrey Kaptein, Suzanne Neyts, Johan Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†) |
title | Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†) |
title_full | Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†) |
title_fullStr | Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†) |
title_full_unstemmed | Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†) |
title_short | Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†) |
title_sort | antiviral treatment of chronic hepatitis b virus (hbv) infections(†) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185710/ https://www.ncbi.nlm.nih.gov/pubmed/21994680 http://dx.doi.org/10.3390/v2061279 |
work_keys_str_mv | AT declercqerik antiviraltreatmentofchronichepatitisbvirushbvinfections AT ferirgeoffrey antiviraltreatmentofchronichepatitisbvirushbvinfections AT kapteinsuzanne antiviraltreatmentofchronichepatitisbvirushbvinfections AT neytsjohan antiviraltreatmentofchronichepatitisbvirushbvinfections |